fda compounding semaglutide crackdown news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounded GLP-1s are entering a
Description
Board-certified FNP Licensed in 18+ states Weight Management Every weight loss plan includes the same level of care Whichever medication option you choose, your monitoring, visits, and support remain the same
Nausea hits 28% of users, vomiting 17%, diarrhea 24%, and constipation 21%
While primarily designed to assess renal outcomes, the trial also demonstrated significant cardiovascular benefits
Evaluation of the Degradation and Metabolic Effects of the Gut Peptide Xenin on Insulin Secretion, Glycaemic Control and Satiety
A personal branding website for Hunter Williams, a biohacking educator and podca.
